CollPlant Biotechnologies CLGN
NASDAQ CLGN
$0.30 -0.02 (-6.51%)
As of: Aug 20, 2026 · 1:52 PM EDT

CollPlant Biotechnologies (CLGN) EPS (Diluted) (2019 - 2026)

CollPlant Biotechnologies (CLGN) EPS (Diluted) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 12.23
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 7.33
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -1.96
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 2.05
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.19
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -0.06
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.15
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -0.72
10 CollPlant Biotechnologies 4.13 Mn 4.13 Mn -243,000.00 -0.26

Historic Data

Download Data
DateValue
Mar 30, 2026 -0.26
Dec 31, 2025 -2.62
Sep 30, 2025 -0.30
Jun 30, 2025 0.00
Mar 30, 2025 -0.14
Dec 31, 2024 -0.41
Sep 30, 2024 -0.39
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 -0.44
Sep 30, 2023 -0.40
Jun 30, 2023 0.00
Mar 31, 2023 0.00
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00
Jun 30, 2021 0.00